Search research articles
Contact Us
Filters
Showing results (51-60 of 364) with videos related to
Page
of 37
Sort By:
Oncoimmunology
|
October 25, 2019
Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade
Oliver Kepp, Laurence Zitvogel, Guido Kroemer
Cell
|
March 23, 2010
Decoding cell death signals in inflammation and immunity
Laurence Zitvogel, Oliver Kepp, Guido Kroemer
Oncoimmunology
|
August 1, 2025
Immuno-oncological effects of the α2-adrenoceptor agonist dexmedetomidine
Lucillia Bezu, Oliver Kepp, Guido Kroemer
Nature Reviews. Microbiology
|
September 7, 2010
Interactions between bacterial pathogens and mitochondrial cell death pathways
Thomas Rudel, Oliver Kepp, Vera Kozjak-Pavlovic
Cancer Immunology Research
|
January 8, 2020
Translating Science into Survival: Report on the Fifth International Cancer Immunotherapy Conference
Mustafa Diken, Oliver Kepp, Arthur N Brodsky
International Review of Cell and Molecular Biology
|
October 25, 2022
Autophagy-inducing nutritional interventions in experimental and clinical oncology
Sebastian J Hofer, Guido Kroemer, Oliver Kepp
Frontiers in Oncology
|
January 5, 2023
Editorial: Anesthesia and cancer: Friend or foe?
Lucillia Bezu, Oscar Díaz-Cambronero, Oliver Kepp
The EMBO Journal
|
January 20, 2007
Bak and Bax are non-redundant during infection- and DNA damage-induced apoptosis
Oliver Kepp, Krishnaraj Rajalingam, Sonja Kimmig, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 10, 2022
A Fluorescence-Microscopic System for Monitoring the Turnover of the Autophagic Substrate p62/SQSTM1
Hongzhong Jin, Qi Wu, Guido Kroemer, et al.
Nature Immunology
|
March 21, 2012
Inflammasomes in carcinogenesis and anticancer immune responses
Laurence Zitvogel, Oliver Kepp, Lorenzo Galluzzi, et al.
Page
of 37
Search research articles
Search
Showing results (51-60 of 364) with videos related to
Sort By:
Page
of 37
Oncoimmunology
|
October 25, 2019
Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade
Oliver Kepp, Laurence Zitvogel, Guido Kroemer
Cell
|
March 23, 2010
Decoding cell death signals in inflammation and immunity
Laurence Zitvogel, Oliver Kepp, Guido Kroemer
Oncoimmunology
|
August 1, 2025
Immuno-oncological effects of the α2-adrenoceptor agonist dexmedetomidine
Lucillia Bezu, Oliver Kepp, Guido Kroemer
Nature Reviews. Microbiology
|
September 7, 2010
Interactions between bacterial pathogens and mitochondrial cell death pathways
Thomas Rudel, Oliver Kepp, Vera Kozjak-Pavlovic
Cancer Immunology Research
|
January 8, 2020
Translating Science into Survival: Report on the Fifth International Cancer Immunotherapy Conference
Mustafa Diken, Oliver Kepp, Arthur N Brodsky
International Review of Cell and Molecular Biology
|
October 25, 2022
Autophagy-inducing nutritional interventions in experimental and clinical oncology
Sebastian J Hofer, Guido Kroemer, Oliver Kepp
Frontiers in Oncology
|
January 5, 2023
Editorial: Anesthesia and cancer: Friend or foe?
Lucillia Bezu, Oscar Díaz-Cambronero, Oliver Kepp
The EMBO Journal
|
January 20, 2007
Bak and Bax are non-redundant during infection- and DNA damage-induced apoptosis
Oliver Kepp, Krishnaraj Rajalingam, Sonja Kimmig, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 10, 2022
A Fluorescence-Microscopic System for Monitoring the Turnover of the Autophagic Substrate p62/SQSTM1
Hongzhong Jin, Qi Wu, Guido Kroemer, et al.
Nature Immunology
|
March 21, 2012
Inflammasomes in carcinogenesis and anticancer immune responses
Laurence Zitvogel, Oliver Kepp, Lorenzo Galluzzi, et al.
Page
of 37